We are an innovative biotechnology company dedicated to providing high-quality products that meet novel customer demands.
Facilities & equipment
→ R&D production headquarters of over 50,000 square feet
→ GMP-production facility of over 100,000 square feet
→ Scientific team of 200 researchers and production engineers
SAMS™ Technology Platform
→ Structure Aided Design and Multiplex Screening (SAMS)
→ Optimizes protein configuration and expression conditions
→ Bioactive proteins in multiple cell lines.
→ Scientific support for structure optimization specific to your application
→ Bulk material supply for research and process development
→ GMP-Grade material for clinical manufacturing
→ Equipment certification, batch records, etc. for regulatory filing
VLP Super Antigens
Many proteins have low abundance or weak immunogenicity. Virus-like-particles (VLPs) derived from self-assembling viral capsid proteins are non-infectious and can elicit an immune response. Our line of VLP-displayed antigens can be used for antibody drug discovery of otherwise difficult targets.